HD-OPM Archive
Topics › LDL, ApoB & lipid panel

2025 ESC/EAS guidelines: LDL-C targets from <55 mg/dL (very high risk) to <116 (low risk)

Louis Nervegna · Nov 06, 2025 · ♥ 4 reactions · 0 comments · original Facebook post
LDL, ApoB & lipid panelGuidelines, policy & public health
↻ This is a repost. The main version (highest ranked) is 2025 ESC/EAS LDL targets: below 55 mg/dL for very high risk, below 70 for high risk · Nov 20, 2025.
AI summary & key facts

Louis summarizes the updated ESC/EAS cholesterol guidelines, which keep tiered LDL-C targets by risk category and add details on who falls into each group. Very high risk patients should aim below 55 mg/dL, and below 40 mg/dL in selected recurrent ASCVD.

Latest 2024 guidelines on LDL levels

(from the European Society of Cardiology)

Family Heart FoundationUpdated Cholesterol Guidelines – What’s New? What’s Changed?The 2025 ESC/EAS cholesterol guidelines reaffirm LDL-C targets, highlight Lp(a) as a key risk factor, and endorse new therapies including bempedoic acid and evinacumab.familyheart.org

Summary:

  1. Very high risk < 55 mg/dL

(Extremely high risk < 40 mg/dL)

  1. High risk < 70 mg/dL
  2. Moderate risk < 100 mg/dL (consider)
  3. Low risk < 116 mg/dL (may consider)

For the details, see below.

The full report from the ESC can be found here:

EscardioLipidology update: targets and timing of well-established therapiesSummary Low-density lipoprotein cholesterol (LDL-C) is the primary target in lipid-lowering strategies. The goal of treatment depends on the level of individual risk in each patient, the goal of which is going to be lower in higher risk patients. The latest European Society of Cardiology (ESC) Guidelines and other recent literature underline that the…escardio.org

DETAILS

————— 1. VERY HIGH RISK —————

Clinical Data

ASCVD, either clinical or unequivocal on imaging (CT scan included in these guidelines)

Diabetes mellitus with target organ damage, long standing duration (>20 years), or associated with other risk factors

eGFR <30 mL/min/1.73 m2

Familial hypercholesterolemia (FH) with ASCVD or with another major risk factor

10 year risk SCORE >10%

LDL-C Target

<55 mg/dL both in primary and secondary prevention

<40 mg/dL in selected patients with recurrent ASCVD

————— 2. HIGH RISK —————

Clinical data

Markedly elevated single risk factors, including total cholesterol >310 mg/dL, LDL-C >190 mg/dL or blood pressure >180/110 mmHg

FH without other risk factors

Diabetes with a duration >10 years or with another risk factor

eGFR 30-59 mL/min/1.73 m2

Calculated 10 year risk SCORE >5% and <10%

LDL-C Target

<70 mg/dL

————— 3. MODERATE RISK —————

Clinical Data

Younger patients (Type 1 diabetes mellitus <35 years; Type 2 diabetes mellitus <50 years) with diabetes mellitus duration <10 years, without other risk factors

Calculated 10 year risk SCORE >1 % and <5%;

LDL-C Target

<100 mg/dL should be considered

————— 4. LOW RISK —————

Clinical data

Low-risk calculated 10 year risk SCORE <1% for fatal cardiovascular disease

LDL-C Target

<116 mg/dL may be considered

#guidelinesHD

Research cited

#riskfactors#diabetes#ascvd#cardiology#cholesterol#egfr#type2diabetes#bloodpressure
← newer: LDL particle size adds nothing once LDL-P or ApoB is knownolder: Mendelian randomization is a poor tool for studying alcohol →